Rotavirusvaccin

1. Fördjupad information om vaccination mot rotavirus. Folkhälsomyndigheten 2019 www.folkhalsomyndigheten.se  
2. Rose J, Hawthorn RL, Watts B, et al. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009; 339: b3653. BMJ (DOI)  
3. Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307: 598-604..

• Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet

Tidigare sakkunniga

• Ingard Løge, spesialist i allmennmedisin, redaktør NEL